Targeting NADPH oxidases for the treatment of cancer and inflammation
about
Mitochondria, calcium, and tumor suppressor Fus1: At the crossroad of cancer, inflammation, and autoimmunityDepolarization Controls TRAIL-Sensitization and Tumor-Selective Killing of Cancer Cells: Crosstalk with ROSIDH1/2 mutations target a key hallmark of cancer by deregulating cellular metabolism in gliomaReduction-oxidation pathways involved in cancer development: a systematic review of literature reviews.Honokiol inhibits ultraviolet radiation-induced immunosuppression through inhibition of ultraviolet-induced inflammation and DNA hypermethylation in mouse skin.Current approaches to the treatment of metastatic brain tumours.Gentian violet: a 19th century drug re-emerges in the 21st centuryReactive oxygen species in normal and tumor stem cells.Proteomic and functional investigation of the colon cancer relapse-associated genes NOX4 and ITGA3Acidosis promotes invasiveness of breast cancer cells through ROS-AKT-NF-κB pathway.Mitigation of NADPH Oxidase 2 Activity as a Strategy to Inhibit Peroxynitrite Formation.PlGF-induced VEGFR1-dependent vascular remodeling determines opposing antitumor effects and drug resistance to Dll4-Notch inhibitors.Effects of iodonium-class flavin dehydrogenase inhibitors on growth, reactive oxygen production, cell cycle progression, NADPH oxidase 1 levels, and gene expression in human colon cancer cells and xenografts.Circadian rhythm connections to oxidative stress: implications for human health.Characterization of NADPH oxidase 5 expression in human tumors and tumor cell lines with a novel mouse monoclonal antibody.E-cadherin re-expression shows in vivo evidence for mesenchymal to epithelial transition in clonal metastatic breast tumor cells.Cambogin exerts anti-proliferative and pro-apoptotic effects on breast adenocarcinoma through the induction of NADPH oxidase 1 and the alteration of mitochondrial morphology and dynamicsMolecular mechanisms underlying chronic inflammation-associated cancers.Prognostic impact of PHIP copy number in melanoma: linkage to ulceration.Oxidative stress, Nox isoforms and complications of diabetes--potential targets for novel therapies.The antioxidant paradox: what are antioxidants and how should they be used in a therapeutic context for cancer.ROS and energy metabolism in cancer cells: alliance for fast growth.Molecular mechanisms involved in gliomagenesis.Loss of INK4a/Arf gene enhances ultraviolet radiation-induced cutaneous tumor development.Therapeutic potential of NADPH oxidase 1/4 inhibitors.Paradoxical roles of dual oxidases in cancer biology.Integrin β1: A Mechanosignaling Sensor Essential for Connective Tissue Deposition by Fibroblasts.RNAi-mediated silencing of NOX4 inhibited the invasion of gastric cancer cells through JAK2/STAT3 signaling.DUOX2 and DUOXA2 form the predominant enzyme system capable of producing the reactive oxygen species H2O2 in active ulcerative colitis and are modulated by 5-aminosalicylic acid.Recent Developments in the Probes and Assays for Measurement of the Activity of NADPH Oxidases.Regulation of anoikis resistance by NADPH oxidase 4 and epidermal growth factor receptor.Superoxide deficiency attenuates promotion of hepatocarcinogenesis by cytotoxicity in NADPH oxidase knockout mice.Regression of diffuse B-cell lymphoma of the leg with intralesional gentian violet.Seborrheic Keratoses: The Rodney Dangerfield of Skin lesions, and Why They Should Get Our Respect.Insights into the HyPer biosensor as molecular tool for monitoring cellular antioxidant capacity.Activated Nrf2 impairs liver regeneration in mice by activation of genes involved in cell-cycle control and apoptosis.Targeting the duality of cancer.Diosgenin inhibits superoxide generation in FMLP-activated mouse neutrophils via multiple pathways.Gene expression and prognosis of NOX family members in gastric cancer.Unraveling the in vitro antitumor activity of Vismia baccifera against HepG2: role of hydrogen peroxide.
P2860
Q26798304-CA27DD8A-DE59-4797-9810-0FE33EC145CFQ26853365-D0726829-01EC-4B99-BD1A-1AC1B694B4EBQ26995506-D0A0DC62-4758-4EEA-BE1C-CEEB6F6DBF8EQ30234584-A0DDF7FB-F659-42F1-9AB3-B3AA7362BADFQ33687663-EFC89E58-E10A-43A2-8268-E00B68616B14Q33696559-A75707CD-9C2E-411A-BA38-77BAEBCC5B6FQ34377198-E1A27861-1F67-494B-9AAB-C9B42B25058BQ34392752-B3A9A5DE-8BAE-42AD-9BB3-43724813B570Q34488582-180B4948-D34C-49C8-B50E-1C04D56FDA51Q35067955-136366A8-F021-4526-A9CB-6538091C63E2Q35912784-81EBCCCA-0A96-4F71-A118-025C388B2189Q36268182-3F78ECC3-59F5-49DE-A139-C299B65AE98EQ36674761-05DF333E-286B-44A1-A873-420F19059236Q36945752-4FA6E8A4-4F00-4EDA-9529-82F9622E0C39Q37384931-2D6A9915-326C-40F3-B924-FABFE40FA2D5Q37536575-50F819DD-0B5B-4C37-895D-44FEDDB2FFFBQ37580432-ACECD9AC-4174-4A83-8AF5-4C6C281E640BQ37605343-9B9AA26A-BE58-4AA9-BF83-A8926F6E5DB6Q37623173-FD0AFA14-8E02-42A3-9F38-E1530D6B6CAFQ38019841-AB4868EA-03B8-4F47-B625-DB746C0A2B60Q38261369-2E1F6898-351D-445A-9D5C-09564BAB2191Q38323297-CE87B60D-F8EC-4F04-A003-F4FAED55C869Q38766569-93CF4D24-C227-43DE-AFB8-8EB53E851886Q38832702-CC79AC2C-7568-4803-A349-94B1E8BF3074Q38858553-6B7305EB-ECA0-4161-9524-C1019408F57BQ39348472-C76937A6-7E7B-4390-80E8-FD90FC9D53F7Q42868438-D1B0CB65-3951-47DB-9540-4FEC72CACE75Q44034196-6AA9D74E-8C64-425E-BD1D-EE63A5B82F76Q46215033-73955835-20AE-495C-862C-DF2393DEB6E1Q46343029-6224A9EA-189E-485C-8FF3-E1D3214A702EQ46433404-C87D955F-965E-4530-AC42-E98C15340C0EQ46844112-CFCFD8DC-F13B-4F7F-AB13-60ECDACAC757Q47790294-178520DD-AE7C-4F46-8D73-EACEC45F5FAAQ48063365-E97ED1E0-EC4C-4F9C-BC92-E698A134B87BQ51741831-2DEB7D62-D28A-4A3B-9A7C-EAD866EA7C6DQ51768533-1987CF60-A7D3-46F7-8CEE-F9C743280D19Q52539731-4DBF42CB-A6C0-49AC-9475-8EA10C4E8F4CQ54320369-07F15C84-7C67-49DD-9688-570AE4FA24F5Q55186854-1185B5A8-76E3-438B-91F4-9BBF3C7890B2Q55564504-00FC4333-2139-4B66-9278-A8F958E88A54
P2860
Targeting NADPH oxidases for the treatment of cancer and inflammation
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Targeting NADPH oxidases for the treatment of cancer and inflammation
@ast
Targeting NADPH oxidases for the treatment of cancer and inflammation
@en
Targeting NADPH oxidases for the treatment of cancer and inflammation
@nl
type
label
Targeting NADPH oxidases for the treatment of cancer and inflammation
@ast
Targeting NADPH oxidases for the treatment of cancer and inflammation
@en
Targeting NADPH oxidases for the treatment of cancer and inflammation
@nl
prefLabel
Targeting NADPH oxidases for the treatment of cancer and inflammation
@ast
Targeting NADPH oxidases for the treatment of cancer and inflammation
@en
Targeting NADPH oxidases for the treatment of cancer and inflammation
@nl
P2860
P3181
P1476
Targeting NADPH oxidases for the treatment of cancer and inflammation
@en
P2093
Jack L. Arbiser
Michael Y. Bonner
P2860
P2888
P304
P3181
P356
10.1007/S00018-012-1017-2
P407
P577
2012-07-01T00:00:00Z
P5875
P6179
1049160285